Daewon Pharmaceutical

• NCT05970679

  Phase 3, Completed, 252 people, 1 Aug 2023

• NCT05836740

  Collaborator, Phase 3, Completed, 1,724 people, 1 May 2023

• NCT03874260

  Phase 4, Status unknown, 180 people, 14 Mar 2019

• NCT03210532

  Phase 3, Completed, 129 people, 7 Jul 2017

• NCT02933658

  Phase 1, Completed, 71 people, 14 Oct 2016

• NCT02390375

  Phase 3, Completed, 348 people, 17 Mar 2015

• NCT01781702

  Phase 3, Completed, 120 people, 1 Feb 2013

• NCT01606059

  Phase 1, Completed, 30 people, 25 May 2012

• Deep learning-based retinal risk stratification for 10-year atherosclerotic cardiovascular mortality in patients with hypertension and diabetes: a retrospective cohort study

  Consulting or advice, Fees or honoraria, 1 Sept 2026

Sources: pubmed.ncbi.nlm.nih.gov